These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2530403)

  • 21. [Clinical use of antiandrogens in the female].
    Moltz L; Schwartz U; Hammerstein J
    Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic alternatives for the hirsute woman.
    Bassaw B; Maharaj R; Ali A; Roopnarinesingh S
    West Indian Med J; 1992 Mar; 41(1):12-4. PubMed ID: 1533080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Venturoli S; Marescalchi O; Colombo FM; Macrelli S; Ravaioli B; Bagnoli A; Paradisi R; Flamigni C
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1304-10. PubMed ID: 10199771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for a non-androgenic anovulant in the management of hirsutism.
    McKenna TJ; Cunningham SK
    Ir J Med Sci; 1991 Jul; 160(7):194-6. PubMed ID: 1757211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
    O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
    J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in H-Y antigen-positive lymphocytes in hirsute women: effects of cyproterone acetate and estradiol treatment.
    Amice V; Bercovici JP; Nahoul K; Hatahet MH; Amice J
    J Clin Endocrinol Metab; 1989 Jan; 68(1):58-62. PubMed ID: 2521223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiandrogens in the treatment of acne and hirsutism.
    Hammerstein J; Moltz L; Schwartz U
    J Steroid Biochem; 1983 Jul; 19(1B):591-7. PubMed ID: 6224974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
    Fruzzetti F; Bersi C; Parrini D; Ricci C; Genazzani AR
    Fertil Steril; 1999 Mar; 71(3):445-51. PubMed ID: 10065780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
    Porcile A; Gallardo E
    Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyproterone acetate as initial treatment and maintenance therapy for hirsutism.
    Holdaway IM; Croxson MS; Ibbertson HK; Sheehan A; Knox B; France J
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):522-9. PubMed ID: 2930987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Beigi A; Sobhi A; Zarrinkoub F
    Int J Gynaecol Obstet; 2004 Oct; 87(1):29-33. PubMed ID: 15464773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The response to gonadotropin-releasing hormone in hirsutism after treatment with cyproterone acetate].
    Kocijancic A; Pfeifer M; Prezelj J; Meden-Vrtovec H; Vrhovec I
    Jugosl Ginekol Opstet; 1982; 22(1-2):16-9. PubMed ID: 6215543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-androgen treatment of hirsutism with cyproterone acetate].
    Kása M; Egyedi K; Raffai S; Török L
    Z Hautkr; 1990 Dec; 65(12):1112-4. PubMed ID: 2150902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parameters.
    Parr JH; Seed M; Godsland I; Wynn V
    J Endocrinol Invest; 1987 Jun; 10(3):237-9. PubMed ID: 2957418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S
    Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid inhibitors of androgen-potentiated actions on skin.
    Ebling FJ; Randall VA
    J Steroid Biochem; 1983 Jul; 19(1B):587-90. PubMed ID: 6224973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of cyproterone acetate with sex hormone binding globulin of monkey plasma.
    Srivastava AK; Dey SB; Roy SK
    Exp Clin Endocrinol; 1983 Aug; 82(2):232-4. PubMed ID: 6226532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
    Sahin Y; Dilber S; Keleştimur F
    Fertil Steril; 2001 Mar; 75(3):496-500. PubMed ID: 11239530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects.
    Jasonni VM; Franceschetti F; Ciotti P; Bulletti C; Vignudelli A; Marabini A; Naldi S; Flamigni C
    Acta Obstet Gynecol Scand; 1986; 65(7):685-7. PubMed ID: 2949483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.